Here are nine key notes on orthopedic and spine device companies over the past week.
Spinal Tech
Swiss Federal Institute of Technology, Lausanne researchers created a new system for spinal cord injury therapy, wirelessly connecting the brain to the spinal cord below the injury, according to The New York Times.
The global minimally invasive neurosurgery devices market is expected to grow through 2025, according to a Future Market Insights report.
The internal watchdog at HHS allegedly told CMS that Canonsburg, Pa.-based Mylan Pharmaceuticals had been improperly classifying its EpiPen since 2009, Reuters reports.
Audubon, Pa.-based Globus Medical reported its third quarter 2016 financial results, according to The Cerbat Gem Market News and Analysis.
Cambridge, Mass.-based InVivo Therapeutics added University of Iowa Hospitals and Clinics in Iowa City as an INSPIRE study clinical site.
Karlsruhe, Germany-based joimax received FDA clearance to market its Vaporflex and Legato electrosurgical probes with radiowave technology.
The Circuit Court of St. Louis (Mo.) County jury ruled in favor of Memphis, Tenn.-based Wright Medical Group following allegations that its metal-on-metal hip implant was defective, according to The National Law Journal.
San Diego-based DJO Global has released its third quarter financial results.
Caesarea, Israel-based Mazor Robotics reported its results for the third quarter, ending Sept. 30, 2016.
